Is nLIGHT (LASR) Using Improved Results and Guidance to Redefine Its Growth Investment Story?

NLIGHT, INC.

NLIGHT, INC.

LASR

0.00

  • In the second quarter of 2026, nLIGHT, Inc. reported revenue of US$82.59 million and a reduced net loss of US$1.34 million, and later issued third-quarter 2026 revenue guidance of US$63 million to US$73 million.
  • The combination of higher revenue, smaller losses, and fresh revenue guidance highlights how nLIGHT’s operations are shifting while it continues to invest for growth.
  • With this backdrop of stronger quarterly performance and new revenue guidance, we’ll now examine how the update may influence nLIGHT’s investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 28 best rare earth metal stocks of the very few that mine this essential strategic resource.

nLIGHT Investment Narrative Recap

To own nLIGHT, you need to believe that high‑power lasers for aerospace and defense, plus a healthier industrial business, can eventually support a path to consistent profitability. The latest quarter’s higher revenue and much smaller loss, combined with Q3 2026 revenue guidance of US$63 million to US$73 million, matters most for testing that profitability path. The biggest near‑term risk remains nLIGHT’s dependence on defense programs and the potential volatility if program funding or timing shifts materially.

Among recent announcements, the launch of the HADES 70 kW‑class high‑energy laser in May 2026 stands out as especially relevant. It connects directly to the defense‑driven growth story behind the stronger Q2 numbers and Q3 guidance, because products like HADES are intended for missile defense and counter‑UAS applications that underpin nLIGHT’s growing role in directed energy. How well these new systems convert into sustained orders will be key to supporting the current catalysts.

Yet despite the recent progress, investors should also weigh the heightened exposure to shifting defense budgets and program timing...

nLIGHT's narrative projects $454.9 million revenue and $8.2 million earnings by 2029.

Uncover how nLIGHT's forecasts yield a $90.71 fair value, a 80% upside to its current price.

Exploring Other Perspectives

LASR 1-Year Stock Price Chart
LASR 1-Year Stock Price Chart

Before this update, the most optimistic analysts were penciling in about US$464 million of revenue and US$35 million of earnings by 2029, which is far more upbeat on defense led growth than the consensus, and shows how differently you and other shareholders might view the same Q2 results and new Q3 guidance.

Explore 5 other fair value estimates on nLIGHT - why the stock might be worth less than half the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your nLIGHT research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
  • Our free nLIGHT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate nLIGHT's overall financial health at a glance.

No Opportunity In nLIGHT?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

  • Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
  • Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
  • AI is about to change healthcare. These 44 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.